21197 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants CpG containing adjuvants; Oligonucleotide containing adjuvants
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
#1202Combination adjuvant formulation
#1203Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
#1204Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction
#1205IMMUNOSTIMULATORY ACTIVITY OF PALINDROMIC IMMUNE MODULATORY OLIGONUCLEOTIDES (IMO) CONTAINING DIFFERENT LENGTHS OF PALINDROMIC SEGMENTS
#1206Synthetic RNA-based agonists of TLR7
#1207COMPOSITIONS COMPRISING AN ANTIGEN, AN AMPHIPATHIC COMPOUND AND A HYDROPHOBIC CARRIER, AND USES THEREOF
#1208Protein vaccines against poxviruses
#1209METHODS OF REDUCING PAPILLOMAVIRUS INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES
#1210RESTRICTIVE AGONIST OF TOLL-LIKE RECEPTOR 3 (TLR3)
#1211Modulation of immunostimulatory properties by small oligonucleotide-based compounds
#1212Immunostimulatory oligonucleotide multimers
#1213COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISEASE
#1214Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity
#1215Secretory IgA and IgG Antibody Inducer
#1216Immunotherapy against several tumors including neuronal and brain tumors
#1217THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE
#1218Oligoribonucleotides and uses thereof
#1219Immunostimulatory oligonucleotides
#1220IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
#1221Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain
#1222Functional influenza virus like particles (VLPs)
#1223Immunogenic compositions comprising polypeptides and fusions thereof
#1224Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions
#1225Methods and compositions for modulating an immune response with immunogenic oligonucleotides
#1226Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune response
#1227ADJUVANTED VACCINE
#1228IMMUNOSTIMULATORY COMBINATIONS AND METHODS
#1229Adjuvant comprising oligonucleotide and non-toxic lipopolysaccharide
#1230Modulation of toll-like receptor 5 expression by antisense oligonucleotides
#1231USE OF STERICALLY STABILIZED CATIONIC LIPOSOMES TO EFFICIENTLY DELIVER CPG OLIGONUCLEOTIDES IN VIVO
#1232Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use
#1233VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
#1234Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates
#1235Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C
#1236Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences
#1237Activation of HCV specific T cells
#1238Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus
#1239VACCINES COMPRISING TB 10.4
#1240Immunogenic complexes and methods relating thereto
#1241Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer
#1242CpG DNA adjuvant in avian vaccines
#1243Human hookworm vaccine
#1244Adjuvant compositions
#1245Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof
#1246Method of elicting or inducing an immune response
#1247Adjuvant compositions
#1248Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
#1249Chimeric immunomodulatory compounds and methods of using the same-II
#1250MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT
#1251Nucleic acid compositions for stimulating immune responses
#1252Fusion proteins of
#1253Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
#1254Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
#1255ADJUVANT
#1256Induction of Indoleamine 2,3-Dioxygenase in Dendritic Cells by TLR Ligands and Uses thereof
#1257NOVEL MEMORY CTL INDUCTION POTENTIATOR
#1258POLYNUCLEOTIDE THERAPY
#1259Methods for identifying peptides that bind to intact oocytes
#1260POLYNUCLEOTIDE THERAPY
#1261Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)
#1262Immunostimulatory oligonucleotides and use thereof in pharmaceuticals
#1263HCV E1E2 vaccine compositions
#1264VACCINE
#1265Inactivated Chimeric Vaccines and Related Methods of Use
#1266Complexed polypeptide and adjuvant for improved vaccines
#1267Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
#1268Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof
#1269Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone
#1270MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION
#1271vaccine
#1272CASB618 Polynucleotides and Polypeptides and Their Use
#1273IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
#1274COMPOSITION AND METHODS OF MAKING AND USING INFLUENZA PROTEINS
#1275Immunogenic compositions for activating γδ T cells
#1276DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
#1277IMMUNOSTIMULATORY NUCLEIC ACIDS
#1278Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant
#1279Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
#1280Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
#1281Method for determining immunostimulatory activity of RNA oligonucleotides
#1282Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant
#1283IMMUNOSTIMULATORY NUCLEIC ACID OIL-IN-WATER FORMULATIONS AND RELATED METHODS OF USE
#1284CpG single strand deoxynucleotides for use as adjuvant
#1285HCV VACCINES
#1286Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
#1287IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF
#1288Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
#1289Herpes simplex virus combined subunit vaccines and methods of use thereof
#1290Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
#1291Semi-soft c-class immunostimulatory oligonucleotides
#1292Multivalent Immunogen
#1293IMMUNIZATION-FREE METHODS FOR TREATING ANTIGEN-STIMULATED INFLAMMATION IN A MAMMALIAN HOST AND SHIFTING THE HOST'S ANTIGEN IMMUNE RESPONSIVENESS TO A TH1 PHENOTYPE
#1294HCV VACCINES
#1295VACCINE
#1296TLR9 agonist and CD40 agonist immunostimulatory combinations
#1297Compositions and methods for immunostimulatory RNA oligonucleotides
#1298NOVEL USE
#1299Methods and compositions for immunization against chlamydial infection and disease
#1300Herpes simplex virus combined subunit vaccines and methods of use thereof
#1301Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#1302ADJUVANTED VACCINE
#1303Method for therapeutic, clinical and veterinary use poly-ICLC
#1304Combination motif immune stimulatory oligonucleotides with improved activity
#1305Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#1306Dry Formulation for Transcutaneous Immunization
#1307Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#1308Immunostimulatory Combinations for Vaccine Adjuvants
#1309Bioactive molecular matrix and methods of use in the treatment of disease
#1310CPG-PACKAGED LIPOSOMES
#1311Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
#1312Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#1313Methods and means for the treatment of HPV induced intraepithelial neoplasia
#1314Immune modulating oligonucleotides in connection with chemotherapeutic measures
#1315Stabilized immune modulatory RNA (SIMRA) compounds
#1316Toll like receptor modulators
#1317CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS
#1318DOUBLE-STRANDED LOCKED NUCLEIC ACID COMPOSITIONS
#1319LYOPHILISED ANTIGEN COMPOSITION
#1320Synthetic Protein as Tumor-Specific Vaccine
#1321Enhancement of immune response to vaccine by interferon alpha
#1322Receptor Binding Polypeptides
#1323Immunomodulatory compositions, methods of making, and methods of use thereof
#1324Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase
#1325Methods and compositions for inducing innate immune responses
#1326Short immunomodulatory oligonucleotides
#1327COMBINATION THERAPY USING ACTIVE IMMUNOTHERAPY
#1328Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant
#1329VACCINES
#1330PROTEIN CAGE IMMUNOTHERAPEUTICS
#1331Viral adjuvants
#1332Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications
#1333Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex
#1334Fusion proteins of
#1335Hiv Gp-41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles as Novel Antigens
#1336Immunostimulating agents
#1337Modulation of NKT cell activity with antigen-loaded CD1d molecules
#1338Oligonucleotides derived from for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell
#1339CANINE INFLUENZA VACCINES
#1340Method for rapid generation of mature dendritic cells
#1341Use of penetration enhancers and barrier disruption methods to enhance the immune response of an antigen
#1342Compositions and methods for preventing or treating a viral infection
#1343Composition having antitumor effect
#1344Adjuvant systems and vaccines
#1345Innate immune system-directed vaccines
#1346CPG-like nucleic acids and methods of use thereof
#1347Receptor binding polypeptides
#1348Immunomodulatory polynucleotides and methods of using the same
#1349Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
#1350VACCINE
#1351Method for enhancing T cell response
#1352IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS
#1353Chimeric immunomodulatory compounds and methods of using the same
#1354Human Hookworm Vaccine
#1355Vaccine delivery compositions and methods of use
#1356Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
#1357Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
#1358Complexed Polypeptide and Adjuvant for Improved Vaccines
#1359VACCINES
#1360Methods and Compositions for Treating Tumors
#1361Methods to bypass CD4+ cells in the induction of an immune response
#1362Sphingolipids' polyalkylamines conjugates
#1363VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV
#1364VACCINES
#1365Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#1366Vaccine Adjuvant
#1367Vaccines
#1368Multiple CpG oligodeoxynucleotides and their use to induce an immune response
#1369Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
#1370Multiple antigenic agents and methods for using the same
#1371Scaffolds for cell transplantation
#1372Immunostimulatory nucleic acid molecules
#1373Influenza virus-like particle (VLP) compositions
#1374Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies
#1375Conjugates for inducing targeted immune responses and methods of making and using same
#1376Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#1377Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
#1378Production of HIV
#1379Immunostimulatory nucleic acid molecules
#1380Combination Therapy for Immunostimulation
#1381Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic and therapeutic purposes
#1382Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
#1383Immunostimulatory oligonucleotides
#1384Methods and compositions for mediation of immune responses and adjuvant activity
#1385Cpg Single Strand Deoxynucleotides for Use as Adjuvant
#1386Synergistic Liposomal Adjuvants
#1387Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#1388Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
#1389Method for stimulating the immune, inflammatory or neuroprotective response
#1390ADJUVANT IN THE FORM OF A LIPID-MODIFIED NUCLEIC ACID
#1391EPITOPE SYNCHRONIZATION IN ANTIGEN PRESENTING CELLS
#1392Chimeric adenoviral vectors
#1393Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof
#1394SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF
#1395Immunomodulatory formulations and methods for use thereof
#1396Immunogenic Hiv Compositions and Related Methods
#1397Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer Immunotherapy
#1398dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
#1399Immunostimulatory nucleic acids
#1400Modified vaccinia ankara expressing P53 in cancer immunotherapy
#1401Immunostimulatory activity of immune modulatory oligonucleotides (IMO™) containing different lengths of palindromic segments
#1402Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity
#1403ANTIGENIC COMPOSITION
#1404Therapeutically useful synthetic oligonucleotides
#1405Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
#1406Vaccine Compositions Comprising An Interleukin 18 And Saponin Adjuvant System
#1407Immunogenic Compositions
#1408Oligodeoxynucleotide and its use to induce an immune response
#1409Immunomodulatory oligonucleotides
#1410High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
#1411Mucosal boosting following parenteral priming
#1412Methods for regulating hematopoiesis using CpG-oligonucleotides
#1413Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
#1414Immunostimulatory oligonucleotide multimers
#1415Immunostimulatory oligonucleotide that induces interferon alpha
#1416Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
#1417Nucleotide sequences promoting the trans-membrane transport of nucleic acids
#1418Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
#1419Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
#1420Immunopotentiator and method for enhancing immunoactivity using the same
#1421Polyinosinic acid-polycytidylic acid-based adjuvant
#1422Innate immune system-directed vaccines
#1423Method for assembling a polymer-biologic delivery composition
#1424Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
#1425Anthrax vaccines and delivery methods
#1426Immunostimulatory oligoribonucleotides
#1427Antigens encoded by alternative reading frames from pathogenic viruses
#1428Methods and compositions for inducing innate immune responses
#1429Innate immune system-directed vaccines
#1430Vaccine delivery
#1431Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP
#1432Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
#1433Short immunomodulatory oligonucleotides
#1434Compositions and methods for enhancing immunity by chemoattractant adjuvants
#1435Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
#1436Polymer-based delivery system for immunotherapy of cancer
#1437Immunostimulatory nucleic acid molecules
#1438Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#1439In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy Vector
#1440Treatment of B cells with IL-21 and B cell activators induces Granzyme B production
#1441Immunostimulatory nucleic acids
#1442Immunostimulatory nucleic acid molecules
#1443Immunostimulatory nucleic acid molecules for activating dendritic cells
#1444Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
#1445Chimeric immunomodulatory compounds and methods of using the same—IV
#1446Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
#1447Canine influenza vaccines
#1448Production of multivalent virus like particles
#1449Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
#1450Compositions and methods to treat and control tumors by loading antigen presenting cells
#1451Compositions comprising structurally stable conjugate molecules
#1452Hcv vaccines
#1453Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
#1454Immunomodulatory oligonucleotides
#1455Inactivated chimeric flavivirus
#1456Immunomodulatory oligonucleotides
#1457Methods and compositions for inducing antigen-specific immune responses
#1458Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
#1459Methods related to immunostimulatory nucleic acid-induced interferon
#1460Avoidance of undesirable replication intermediates in plasmid propagation
#1461Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
#1462Vaccines
#1463Sphingolipids polyalkylamine conjugates for use in transfection
#1464Sphingoid polyalkylamine conjugates for vaccination
#1465Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
#1466Packaged virus-like particles
#1467Methods and products related to treatment and prevention of hepatitis C virus infection
#1468Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases
#1469Methods for treating infectious disease exacerbated asthma
#1470Induction of mucosal immunity by vaccination via the skin route
#1471Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs
#1472Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
#1473Immunostimulatory oligonucleotides
#1474Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
#1475Hiv-peptide-carrier-conjugates
#1476Helper virus-free herpesvirus amplicon particles and uses thereof
#1477Melan-A- carrier conjugates
#1478Lna-cpg conjugates
#1479Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
#1480Immunostimulatory, covalently lipidated oligonucleotides
#1481Methods and products for enhancing immune responses using imidazoquinoline compounds
#1482Cpg-packaged liposomes
#1483Non-human animal models for diabetic complications and their uses
#1484Compositions of CpG and saponin adjuvants and uses thereof
#1485Composition and method for preventing or treating a virus infection
#1486Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
#1487Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
#1488Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides
#1489Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
#1490Methods for the accumulation and retention of immune-enhancing, bacterial-derived ribonucleotides (ORN) in bacteria
#1491Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
#1492Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#1493Semi-soft C-class immunostimulatory oligonucleotides
#1494Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#1495Synergistic inhibition of VEGF and modulation of the immune response
#1496Vaccine comprising il-13 and an adjuvant
#1497Immunomodulatory oligonucleotides
#1498Immunostimulatory oligonucleotide multimers
#1499Immunostimulatory oligonucleotide multimers
#1500Immunostimulatory nucleic acid molecules